📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Rainbow Children's Medicare Q3 FY26: Revenue Up 12% to ₹445 Cr; New CEO Appointed
Rainbow Children's Medicare reported a 12% YoY revenue growth to ₹445.4 crores for Q3 FY26, while PAT grew 7% to ₹73.9 crores. The company is transitioning from a heavy expansion phase to an execution phase, having recently commissioned hospitals in Rajahmundry and Electronic City. Despite steady operational growth in deliveries (up 16%) and IP discharges (up 9%), occupancy remained at 47.2% due to muted seasonal illnesses. The appointment of Abrarali Dalal as CEO and a strong cash reserve of ₹579 crores position the company for future organic and inorganic growth.
Key Highlights
Revenue grew 12% YoY to ₹445.4 crores; EBITDA increased 9% to ₹147 crores with a 33% margin.
Deliveries saw an impressive 16% YoY growth, while IP discharges and OP volumes rose by 9% and 18% respectively.
Maintains a robust balance sheet with ₹579 crores in cash to fund future CAPEX and M&A through internal accruals.
Commissioned 100-bed Rajahmundry and 90-bed Electronic City units; 60-bed Hennur unit awaiting final approvals.
Successful first pediatric liver transplant in Bengaluru hub, achieving a 94% survival rate across the network.
💼 Action for Investors
Investors should monitor the ramp-up of new units and the impact of the new CEO on improving occupancy levels, which currently sit below 50%. The stock remains a solid long-term play on specialized pediatric healthcare given the strong cash position and execution focus.
Rainbow Children's Medicare Q3 FY26 Revenue Up 21% YoY; OP Consultations Surge 18%
Rainbow Children's Medicare reported a robust 21.2% YoY growth in operating revenue for Q3 FY26, reaching ₹4,057 million. The company witnessed strong volume growth with out-patient consultations increasing by 18% and in-patient discharges by 9%. Expansion remains a key theme, with three new hospitals operationalized in Warangal, Guwahati, and Rajahmundry during the fiscal year. While EBITDA grew 14.3% to ₹1,313 million, overall occupancy moderated to 47.2% due to the significant addition of new capacity beds.
Key Highlights
Operating Revenue increased 21.2% YoY to ₹4,057 million in Q3 FY26.
EBITDA stood at ₹1,313 million, up 14.3% YoY, with a margin of 32.4%.
Out-patient consultations grew 18% YoY to 4,17,342; In-patient discharges rose 9% to 27,977.
ARPOB (Average Revenue Per Occupied Bed) improved by 9% YoY to ₹58,362.
Total capacity beds reached 2,285 following the addition of hospitals in Warangal, Guwahati, and Rajahmundry.
💼 Action for Investors
Investors should monitor the occupancy levels and margin stabilization as the newly added hospitals move through their gestation periods. The strong growth in OP consultations and ARPOB suggests healthy underlying demand for specialized pediatric services.
Rainbow Children’s Q3 Revenue Up 11.9% YoY to ₹445 Cr; Focus Shifts to Execution
Rainbow Children’s Medicare reported a steady Q3 FY26 with revenue growing 11.9% YoY to ₹4,454 Mn and PAT increasing 7.2% to ₹739 Mn. While operational capacity expanded by 18% to 2,285 beds, occupancy rates dipped to 47.19% from 53.20% YoY due to the rapid addition of new units in Rajahmundry and Bengaluru. The company has largely completed its current expansion cycle and is now focusing on operational excellence and ramping up occupancy in new facilities. A strong cash position of ₹5,792 Mn supports future growth and ongoing projects in Gurugram and Pune without external debt.
Key Highlights
Revenue grew 11.9% YoY to ₹4,454 Mn, while EBITDA margins remained healthy at 33.0%.
Operational beds increased by 15% to 1,758, though occupancy fell 601 bps to 47.19% due to new capacity additions.
ARPOB (Average Revenue Per Occupied Bed) improved by 9% YoY to ₹58,362.
Commissioned two new hospitals in Rajahmundry (100 beds) and Electronic City, Bengaluru (90 beds).
Maintains a robust cash and investment balance of ₹5,792 Mn as of December 31, 2025.
💼 Action for Investors
Investors should monitor the occupancy ramp-up in newly commissioned units, as the shift from expansion to execution is expected to drive margin improvement. The company's ability to fund large-scale expansions in NCR and Pune through internal accruals remains a significant long-term positive.
Rainbow Children's Medicare Q3 Standalone PAT at ₹658.2 Mn, Revenue Up 3.4% YoY
Rainbow Children's Medicare reported a standalone revenue of ₹3,943.52 million for Q3 FY26, a 3.4% increase over ₹3,815.65 million in Q3 FY25. Standalone Profit After Tax (PAT) declined slightly by 1.7% YoY to ₹658.24 million, down from ₹669.75 million. Sequentially, the performance was lower than Q2 FY26, where revenue was ₹4,084.96 million and PAT was ₹731.67 million. The board also confirmed the appointment of Mr. Abrarali Dalal as CEO starting January 2026.
Key Highlights
Standalone Revenue from operations grew 3.35% YoY to ₹3,943.52 million
Standalone Profit After Tax (PAT) decreased by 1.7% YoY to ₹658.24 million
Total expenses rose to ₹3,166.74 million from ₹3,023.00 million in the previous year's quarter
Basic EPS for the quarter stood at ₹6.48 compared to ₹6.60 in Q3 FY25
Mr. Abrarali Dalal officially took charge as the Chief Executive Officer (CEO) on January 20, 2026
💼 Action for Investors
The results indicate a period of consolidation with flat YoY profit growth and a sequential dip in margins. Investors should monitor the new CEO's impact on operational efficiency and the company's expansion strategy in the specialized pediatric healthcare market.
Rainbow Children's Medicare Launches 90-Bed Hospital in Bengaluru; Total Capacity at 2,375 Beds
Rainbow Children’s Medicare Limited (RCML) has inaugurated a new 90-bed spoke hospital in Electronic City, Bengaluru, increasing its total capacity to approximately 2,375 beds. The project, costing approximately ₹55 crore, was funded entirely through internal accruals, demonstrating strong cash flow management. This facility marks the company's fifth hospital in Bengaluru and will operate under the hub-and-spoke model linked to the Marathahalli hub. This expansion targets a high-growth corridor with a young population, enhancing the company's footprint in a key focus market.
Key Highlights
New 90-bed spoke hospital launched in Electronic City, Bengaluru, increasing total capacity to ~2,375 beds.
Total project investment of approximately ₹55 crore financed through internal accruals.
Strengthens the hub-and-spoke model in Bengaluru, serving as a spoke to the Marathahalli hub.
Company occupancy stood at 46.3% in Q2 FY 2025-26 prior to this addition.
The facility offers comprehensive pediatric and perinatal services, including neonatal and pediatric intensive care.
💼 Action for Investors
The expansion is a positive indicator of the company's growth strategy and ability to scale using internal funds. Investors should monitor the occupancy ramp-up at the new facility to assess its impact on future earnings.